Pure insulin-producing cells produced in mouse

November 21, 2008

Cells effective in treating diabetes in lab model

Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).

These pure insulin-producing cells, which according to electron microscopy studies, have the same sub-cellular structures as the insulin-producing cells naturally found in the pancreas, were highly effective in treating diabetes in the mouse model.

The transplants of pure insulin-producing cells reduced the blood glucose levels of diabetic mice with high blood glucose levels.

The experiments also showed that the subsequent removal of the transplanted cells from the diabetic mice restored the blood glucose to its original high level.

None of the diabetic mice involved in the transplant experiments developed teratoma, which are a type of tumour often associated with ESCs and which could complicate their use in human therapeutic treatment.

Furthermore, the pure insulin-producing cells managed to retain their insulin-production and glucose-sensing capacity over time.

The Singapore researchers' achievement provides proof of principle that this strategy could be applied to human ESCs to obtain similar pure insulin-producing cells.

These research findings were published in two separate papers in the July and August 2008 online versions of the journal Stem Cell Research.

Conducting the research were scientists at the Institute of Medical Biology (IMB), which is under Singapore's Agency for Science, Technology and Research (A*STAR), and the Yong Loo Lin School of Medicine (YLLSoM ) at the National University of Singapore (NUS).

The team of researchers was co-led by Dr. Lim Sai Kiang, an IMB principal investigator and a research associate professor at the YLLSoM Department of Surgery, and Dr. Li Guodong, a research associate professor at National University Medical Institutes, YLLSoM, NUS.

Commenting about these findings, Dr. Gordon Weir, Director of the Clinical Islet Transplantation Program at Harvard Medical School, who also holds appointments at the Harvard Stem Cell Institute and Joslin Diabetes Centre, said, "The amount of careful work done by this group of researchers is impressive. We need something to put into diabetic patients to treat their condition, and these findings tell us interesting things about the development of beta cells."

The strategic approach by the group offers avenues for further research in the treatment for diabetes. Said Dr. Lim, "Our ability to isolate and then multiply insulin-producing cells from differentiating ESCs provides an unlimited supply of pure insulin-producing cells to study in unprecedented detail many aspects of these cells."

Added Dr Li, "Besides providing a tool to facilitate basic research in test tubes and animals, these insulin-producing cells may be also used to replace the isolated native pancreatic cells that are hard to obtain in a large amount, for pharmacological tests".

Agency for Science, Technology and Research (A*STAR), Singapore

---

---

	PR Newswire : Procter & Gamble Announces Strategic Alliance with GMP Companies forNovel Treatment of Diabetes Mellitus; Naturally Occurring Peptide Stimulates the Growth of Insulin-Producing Cells. by PR Newswire Association LLC (Publisher)
	Embryonic stem cells transformed into insulin-producing cells and cardiac tissue, Israeli researchers report.: An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on August 17, 2001. The length of the article is 692 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Embryonic stem cells transformed into insulin-producing cells and cardiac tissue, Israeli researchers report. Publication: Transplant News (Newsletter) Date: August 17, 2001 Publisher: Transplant Communications, Inc. Volume: 11 Issue: 15 Page: NA Distributed by Thomson...
	Stem cell researchers successfully generate new insulin-producing cells which could treat diabetics.: An article from: Transplant News by Unavailable (Author) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on September 1, 2009. The length of the article is 310 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Stem cell researchers successfully generate new insulin-producing cells which could treat diabetics. Author: Unavailable Publication: Transplant News (Newsletter) Date: September 1, 2009 Publisher: Transplant Communications, Inc. Volume: 19 Issue: 9 Page: NA Distributed by Gale, a part of Cengage...
	US Airman injured in Afghanistan receives unprecedented lifesaving insulin producing cell transplant.: An article from: Transplant News by Unavailable (Author) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on December 1, 2009. The length of the article is 530 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: US Airman injured in Afghanistan receives unprecedented lifesaving insulin producing cell transplant. Author: Unavailable Publication: Transplant News (Newsletter) Date: December 1, 2009 Publisher: Transplant Communications, Inc. Volume: 19 Issue: 12 Page: NA Distributed by Gale, a part of Cengage...
	Insulin-producing cells regenerate: mouse experiments suggest potential diabetes treatment.(Body & Brain): An article from: Science News by Tina Hesman Saey (Author) This digital document is an article from Science News, published by Science Service, Inc. on May 8, 2010. The length of the article is 400 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Insulin-producing cells regenerate: mouse experiments suggest potential diabetes treatment.(Body & Brain) Author: Tina Hesman Saey Publication: Science News (Magazine/Journal) Date: May 8, 2010 Publisher: Science Service, Inc. Volume: 177 Issue: 10 Page: 12(1) Distributed by Gale, a part of Cengage...
	Dolly's creators announce plans to use stem cells to create insulin-producing islet cells for treating diabetes.(Brief Article): An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on March 16, 2001. The length of the article is 352 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Dolly's creators announce plans to use stem cells to create insulin-producing islet cells for treating diabetes.(Brief Article) Publication: Transplant News (Newsletter) Date: March 16, 2001 Publisher: Transplant Communications, Inc. Volume: 11 Issue: 5 Page: NA Article Type: Brief Article Distributed by Thomson...
	Biotech company that cloned Dolly to treat diabetics by creating insulin-producing islet cells using stem cells.(Brief Article): An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on November 30, 2000. The length of the article is 723 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Biotech company that cloned Dolly to treat diabetics by creating insulin-producing islet cells using stem cells.(Brief Article) Publication: Transplant News (Newsletter) Date: November 30, 2000 Publisher: Transplant Communications, Inc. Volume: 10 Issue: 22 Page: NA Article Type: Brief Article Distributed by Thomson...
	Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin--Completely Revised and Updated by Gary Scheiner (Author) Few diabetes books focus specifically on the day-to-day issues facing people who use insulin. In this fully updated and revised edition, diabetes educator Gary Scheiner provides the tools to “think like a pancreas”—to successfully master the art and science of matching insulin to the body’s ever-changing needs. Comprehensive, free of medical jargon, and packed with useful information not readily available elsewhere, this new edition covers the many strides taken in diabetes education and management since the first edition seven years ago. Think Like a Pancreas includes critical information, such as day-to-day blood glucose control and monitoring, designing an insulin program to best match your lifestyle, up-to date medication and technology, and new insulin formulations and...
	Growing insulin-producing pancreatic islet cells could increase transplants in diabetics.(Brief Article): An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on July 14, 2000. The length of the article is 450 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Growing insulin-producing pancreatic islet cells could increase transplants in diabetics.(Brief Article) Publication: Transplant News (Newsletter) Date: July 14, 2000 Publisher: Transplant Communications, Inc. Volume: 10 Issue: 13 Page: NA Article Type: Brief Article Distributed by Thomson...
	Stem cell and gene transfer-based approaches to generate insulin-producing cells. by Eszter Pais (Author) The incidence of Diabetes Mellitus (DM) continues to increase with approximately 7.8% of the population affected in the US alone. Although pancreatic beta cell transplantation has the potential to cure the disease, limited donor tissue availability poses a major challenge. Aiming to overcome this critical shortage, we utilized two distinct, lentiviral vector-based approaches to generate or expand insulin-positive cells ex vivo. The first set of experiments was aimed at inducing the controlled proliferation of human pancreatic beta cells through the specific activation of the Hepatocyte Growth Factor (HGF) signaling pathway in beta cells. This goal was achieved by the lentiviral delivery of a novel fusion protein (F36Vcmet) into the target cell population. Notably, this transmembrane...